
C7  - pp. i-liii
TI  - Subject Index
SN  - 9781118870143
UR  - https://doi.org/10.1002/9781118873434.index
DO  - doi:10.1002/9781118873434.index
SP  - i-liii
KW  - No keyword
PY  - 2014
ER  - 

TY  - JOUR
TI  - Front Index and Abstracts
JO  - International Journal of Stroke
JA  - Int J Stroke
VL  - 8
IS  - S3
SN  - 9781118870143
UR  - https://doi.org/10.1111/ijs.12213
DO  - doi:10.1111/ijs.12213
SP  - vii
EP  - 75
PY  - 2013
ER  - 

TY  - JOUR
TI  - ANZSNM Poster Presentations
JO  - Internal Medicine Journal
VL  - 42
IS  - s3
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1445-5994.2012.02873.x
DO  - doi:10.1111/j.1445-5994.2012.02873.x
SP  - 18
EP  - 52
PY  - 2012
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - Journal of Sleep Research
VL  - 21
IS  - s1
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1365-2869.2012.01044.x
DO  - doi:10.1111/j.1365-2869.2012.01044.x
SP  - 1
EP  - 371
PY  - 2012
ER  - 

TY  - JOUR
TI  - 44th Annual Meeting of the Child Neurology Society
JO  - Annals of Neurology
JA  - Ann Neurol.
VL  - 78
IS  - S19
SN  - 9781118870143
UR  - https://doi.org/10.1002/ana.24477
DO  - doi:10.1002/ana.24477
SP  - S133
EP  - S242
PY  - 2015
ER  - 

TY  - JOUR
TI  - Oral Abstracts
JO  - Colorectal Disease
VL  - 13
IS  - s4
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1463-1318.2011.02660.x
DO  - doi:10.1111/j.1463-1318.2011.02660.x
SP  - 1
EP  - 14
PY  - 2011
ER  - 

TY  - JOUR
TI  - Oral Sessions and Poster Sessions
JO  - Tissue Antigens
JA  - Tissue Antigens
VL  - 84
IS  - 1
SN  - 9781118870143
UR  - https://doi.org/10.1111/tan.12371
DO  - doi:10.1111/tan.12371
SP  - 5
EP  - 164
PY  - 2014
ER  - 

TY  - JOUR
AU  - Peng, Zhao Feng
AU  - Chen, Minghui Jessica
AU  - Manikandan, Jayapal
AU  - Melendez, Alirio J.
AU  - Shui, Guanghou
AU  - Russo-Marie, Françoise
AU  - Whiteman, Matthew
AU  - Beart, Philip M.
AU  - Moore, Philip K.
AU  - Cheung, Nam Sang
TI  - Multifaceted role of nitric oxide in an in vitro mouse neuronal injury model: transcriptomic profiling defines the temporal recruitment of death signalling cascades
JO  - Journal of Cellular and Molecular Medicine
VL  - 16
IS  - 1
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1582-4934.2011.01288.x
DO  - doi:10.1111/j.1582-4934.2011.01288.x
SP  - 41
EP  - 58
KW  - nitric oxide
KW  - neuronal injury
KW  - oxidative stress
KW  - microarray
KW  - reactive oxygen species
KW  - reactive nitrogen species
PY  - 2012
AB  - Abstract Nitric oxide is implicated in the pathogenesis of various neuropathologies characterized by oxidative stress. Although nitric oxide has been reported to be involved in the exacerbation of oxidative stress observed in several neuropathologies, existent data fail to provide a holistic description of how nitrergic pathobiology elicits neuronal injury. Here we provide a comprehensive description of mechanisms contributing to nitric oxide induced neuronal injury by global transcriptomic profiling. Microarray analyses were undertaken on RNA from murine primary cortical neurons treated with the nitric oxide generator DETA-NONOate (NOC-18, 0.5 mM) for 8?24 hrs. Biological pathway analysis focused upon 3672 gene probes which demonstrated at least a ±1.5-fold expression in a minimum of one out of three time-points and passed statistical analysis (one-way anova,?P?< 0.05). Numerous enriched processes potentially determining nitric oxide mediated neuronal injury were identified from the transcriptomic profile: cell death, developmental growth and survival, cell cycle, calcium ion homeostasis, endoplasmic reticulum stress, oxidative stress, mitochondrial homeostasis, ubiquitin-mediated proteolysis, and GSH and nitric oxide metabolism. Our detailed time-course study of nitric oxide induced neuronal injury allowed us to provide the first time a holistic description of the temporal sequence of cellular events contributing to nitrergic injury. These data form a foundation for the development of screening platforms and define targets for intervention in nitric oxide neuropathologies where nitric oxide mediated injury is causative.
ER  - 

TY  - JOUR
TI  - 14th ISN MEETING, MONTPELLJER, FRANCE
JO  - Journal of Neurochemistry
VL  - 61
IS  - s1
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1471-4159.1993.tb13441.x
DO  - doi:10.1111/j.1471-4159.1993.tb13441.x
SP  - 1
EP  - 285
PY  - 1993
ER  - 

TY  - JOUR
TI  - Winter Meeting. Abstracts of the 211th Meeting of the Pathological Society of Great Britain & Ireland, 22–23 January 2019, London
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 248
IS  - S1
SN  - 9781118870143
UR  - https://doi.org/10.1002/path.5276
DO  - doi:10.1002/path.5276
SP  - S1
EP  - S23
PY  - 2019
ER  - 

TY  - JOUR
TI  - Pathological Society of Great Britain and Ireland. 182nd meeting, 3–5 January 2001
JO  - The Journal of Pathology
JA  - J. Pathol.
VL  - 193
IS  - 1
SN  - 9781118870143
UR  - https://doi.org/10.1002/path.1711930102
DO  - doi:10.1002/path.1711930102
SP  - A1
EP  - A49
PY  - 2001
ER  - 

TY  - JOUR
AU  - Bull, Sarah
AU  - Burnett, Karin
AU  - Vassaux, Kate
AU  - Ashdown, Lini
AU  - Brown, Terry
AU  - Rushton, Lesley
C7  - 572E
TI  - Extensive literature search and provision of summaries of studies related to the oral toxicity of perfluoroalkylated substances (PFASs), their precursors and potential replacements in experimental animals and humans. Area 1: Data on toxicokinetics (absorption, distribution, metabolism, excretion) in in vitro studies, experimental animals and humans. Area 2: Data on toxicity in experimental animals. Area 3: Data on observations in humans
JO  - EFSA Supporting Publications
JA  - EFSA Supporting Publications
VL  - 11
IS  - 4
SN  - 9781118870143
UR  - https://doi.org/10.2903/sp.efsa.2014.EN-572
DO  - doi:10.2903/sp.efsa.2014.EN-572
SP  - 572E
KW  - perfluoroalkylated substances
KW  - toxicity
KW  - in vitro
KW  - experimental animals
KW  - humans
KW  - literature search
PY  - 2014
ER  - 

TY  - JOUR
TI  - Poster Listings
JO  - Asia-Pacific Journal of Clinical Oncology
VL  - 6
IS  - s3
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1743-7563.2010.01359_7.x
DO  - doi:10.1111/j.1743-7563.2010.01359_7.x
SP  - 82
EP  - 97
PY  - 2010
ER  - 

TY  - JOUR
TI  - Abstracts 200–407
JO  - Hepatology
JA  - Hepatology
VL  - 52
IS  - S1
SN  - 9781118870143
UR  - https://doi.org/10.1002/hep.23979
DO  - doi:10.1002/hep.23979
SP  - 422A
EP  - 522A
PY  - 2010
ER  - 

TY  - JOUR
TI  - E-posters
JO  - Basic and Applied Pathology
VL  - 4
IS  - s1
SN  - 9781118870143
UR  - https://doi.org/10.1111/j.1755-9294.2010.01094_3.x
DO  - doi:10.1111/j.1755-9294.2010.01094_3.x
SP  - 70
EP  - 107
PY  - 2011
ER  - 

TY  - JOUR
TI  - 10:45-12:45
JO  - BJU International
VL  - 90
IS  - s2
SN  - 9781118870143
UR  - https://doi.org/10.1046/j.1464-410X.90.s2.841.x
DO  - doi:10.1046/j.1464-410X.90.s2.841.x
SP  - 1
EP  - 36
PY  - 2002
ER  - 

TY  - JOUR
TI  - Poster Abstracts
JO  - Colorectal Disease
JA  - Colorectal Dis
VL  - 19
IS  - S4
SN  - 9781118870143
UR  - https://doi.org/10.1111/codi.13851
DO  - doi:10.1111/codi.13851
SP  - 14
EP  - 64
PY  - 2017
ER  - 

TY  - JOUR
TI  - Abstracts
JO  - American Journal of Transplantation
JA  - American Journal of Transplantation
VL  - 14
IS  - S2
SN  - 9781118870143
UR  - https://doi.org/10.1111/ajt.12617
DO  - doi:10.1111/ajt.12617
SP  - 51
EP  - 108
PY  - 2014
AB  - First page of article
ER  - 

TY  - JOUR
AU  - Molina, Pablo
AU  - Carrero, Juan J.
AU  - Bover, Jordi
AU  - Chauveau, Philippe
AU  - Mazzaferro, Sandro
AU  - Torres, Pablo Ureña
AU  - for the European Renal Nutrition (ERN) and Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) Working Groups of the European Renal Association–European Dialysis Transplant Association (ERA-EDTA)
C8  - JCSM-D-16-00260
TI  - Vitamin D, a modulator of musculoskeletal health in chronic kidney disease
JO  - Journal of Cachexia, Sarcopenia and Muscle
JA  - Journal of Cachexia, Sarcopenia and Muscle
VL  - 8
IS  - 5
SN  - 9781118870143
UR  - https://doi.org/10.1002/jcsm.12218
DO  - doi:10.1002/jcsm.12218
SP  - 686
EP  - 701
KW  - Bone
KW  - Chronic kidney disease
KW  - Muscle
KW  - Physical performance
KW  - Vitamin D
PY  - 2017
AB  - Abstract The spectrum of activity of vitamin D goes beyond calcium and bone homeostasis, and growing evidence suggests that vitamin D contributes to maintain musculoskeletal health in healthy subjects as well as in patients with chronic kidney disease (CKD), who display the combination of bone metabolism disorder, muscle wasting, and weakness. Here, we review how vitamin D represents a pathway in which bone and muscle may interact. In vitro studies have confirmed that the vitamin D receptor is present on muscle, describing the mechanisms whereby vitamin D directly affects skeletal muscle. These include genomic and non-genomic (rapid) effects, regulating cellular differentiation and proliferation. Observational studies have shown that circulating 25-hydroxyvitamin D levels correlate with the clinical symptoms and muscle morphological changes observed in CKD patients. Vitamin D deficiency has been linked to low bone formation rate and bone mineral density, with an increased risk of skeletal fractures. The impact of low vitamin D status on skeletal muscle may also affect muscle metabolic pathways, including its sensitivity to insulin. Although some interventional studies have shown that vitamin D may improve physical performance and protect against the development of histological and radiological signs of hyperparathyroidism, evidence is still insufficient to draw definitive conclusions.
ER  - 

TY  - JOUR
TI  - Poster Presentations
JO  - Internal Medicine Journal
JA  - Intern Med J
VL  - 47
IS  - S1
SN  - 9781118870143
UR  - https://doi.org/10.1111/imj.13423
DO  - doi:10.1111/imj.13423
SP  - 24
EP  - 43
PY  - 2017
ER  - 
